Spectrum Asset Management (California)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Spectrum Asset Management (California)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-28,731	Closed	-$2.13M	–	95
2022 Q2	$2.13M	Buy	+28,731	New	+$2.16M	1.05%	28
2017 Q4	–	Sell	-32,480	Closed	-$2.81M	–	82
2017 Q3	$2.81M	Buy	32,480 +410	+1%	+$32.9K	2.41%	10
2017 Q2	$2.48M	Sell	32,070 -230	-0.7%	-$16.3K	2.29%	10
2017 Q1	$2.24M	Buy	32,300 +180	+0.6%	+$12.1K	2.06%	9
2016 Q4	$1.9M	Buy	32,120 +14,225	+79%	+$878K	1.84%	12
2016 Q3	$1.19M	Buy	+17,895	New	+$1.11M	1.28%	18

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Spectrum Asset Management (California)'s XBI Position: Q3 2022 in Review

Spectrum Asset Management (California) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 28,731 shares — an estimated $2.13M sold.

Spectrum Asset Management (California) first reported a position in XBI in Q3 2016 and held it in 6 quarters. The position peaked at $2.81M in Q3 2017. 703 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Spectrum Asset Management (California) reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
Spectrum Asset Management (California) sold 28,731 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $2.13M.
Spectrum Asset Management (California) first reported a position in State Street SPDR S&P Biotech ETF in Q3 2016 and held it in 6 quarters.
Spectrum Asset Management (California)'s State Street SPDR S&P Biotech ETF position peaked at $2.81M in Q3 2017.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Spectrum Asset Management (California)'s 13F filing for Q3 2022, filed 25 Oct 2022.